West Houston Clinical Research Services   Report issue

For profit Phase 1 Phase 2
Founded: Houston TX United States (2008)

Organization Overview

First Clinical Trial
2013
NCT02086227
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

West Houston Clinical Research Service

Active Ingredients

Drugs in Phase 2 Trials (1)

moxidectin (1 trial)

Drugs in Phase 1 Trials (1)

glucagon (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypoglycemia (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2